WIKKON® Receives FDA Clearance forU200 Extracorporeal Shock Wave Lithotripter
Singapore and Shenzhen, China, 30 June 2025 – WIKKON®, China’s market leader in urology and shock wave therapy devices, today announced U.S. FDA 510(k) clearance for its U200 Extracorporeal Shock Wave Lithotripter. This marks a key turning point for the company and reinforces its readiness to expand globally, as FDA clearance is widely recognized as…